Dr Raja Rajeswari Senguttuvan, MD, | |
100 Woods Rd, Department Of Pediatrics, Division Of Newborn Medicine, Valhalla, NY 10595-1530 | |
(914) 493-8558 | |
Not Available |
Full Name | Dr Raja Rajeswari Senguttuvan |
---|---|
Gender | Female |
Speciality | Pediatrics - Neonatal-perinatal Medicine |
Location | 100 Woods Rd, Valhalla, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134412885 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2080N0001X | Pediatrics - Neonatal-perinatal Medicine | 245582 (New York) | Primary |
Entity Name | Pratt Pediatric Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477590511 PECOS PAC ID: 3779475371 Enrollment ID: O20040329000127 |
News Archive
Where on one hand the use of ecstasy is falling in Australia, experts are warning that the use of dangerous designer synthetic drugs, which can be made legally, may begin to rise. Ecstasy, one of the most popular "recreational" drugs in Australia over the past two decades is becoming less popular with regular users, consistent with global trends, say the authors of a new report from the National Drug and Alcohol Research Centre at the University of NSW.
Statins, a class of drugs used to lower cholesterol, are among the best selling drugs in North America and around the world. However, statin myopathy, which results in muscle pain and weakness, is a common side effect affecting up to 10 percent of statin users. A recent study led by Dr. Richard Kim of the Lawson Health Research Institute, in collaboration with Dr. Robert Hegele of Robarts Research Institute, and researchers from Vanderbilt University, found that commonly occurring genetic variations in a person's genes could put them at risk for statin-associated muscle injury.
Visterra, Inc., a developer of novel therapeutics to prevent and treat major infectious diseases, today announced that it has received $8.1 million in proceeds from an upsized and final closing of its Series A financing round. The company also announced that it has deepened its executive management team by appointing two industry veterans to newly created roles, which follows the recent appointment of Brian Pereira, M.D. as President and Chief Executive Officer of Visterra this past summer.
Researchers at the University of Colorado School of Medicine have figured out intimate details of how the hepatitis C virus takes over an invaded cell, a breakthrough that could point to way for new treatments for the virus.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Raja Rajeswari Senguttuvan, MD, 177 White Plains Rd, Apt 15f, Tarrytown, NY 10591-5518 Ph: (914) 631-7716 | Dr Raja Rajeswari Senguttuvan, MD, 100 Woods Rd, Department Of Pediatrics, Division Of Newborn Medicine, Valhalla, NY 10595-1530 Ph: (914) 493-8558 |
News Archive
Where on one hand the use of ecstasy is falling in Australia, experts are warning that the use of dangerous designer synthetic drugs, which can be made legally, may begin to rise. Ecstasy, one of the most popular "recreational" drugs in Australia over the past two decades is becoming less popular with regular users, consistent with global trends, say the authors of a new report from the National Drug and Alcohol Research Centre at the University of NSW.
Statins, a class of drugs used to lower cholesterol, are among the best selling drugs in North America and around the world. However, statin myopathy, which results in muscle pain and weakness, is a common side effect affecting up to 10 percent of statin users. A recent study led by Dr. Richard Kim of the Lawson Health Research Institute, in collaboration with Dr. Robert Hegele of Robarts Research Institute, and researchers from Vanderbilt University, found that commonly occurring genetic variations in a person's genes could put them at risk for statin-associated muscle injury.
Visterra, Inc., a developer of novel therapeutics to prevent and treat major infectious diseases, today announced that it has received $8.1 million in proceeds from an upsized and final closing of its Series A financing round. The company also announced that it has deepened its executive management team by appointing two industry veterans to newly created roles, which follows the recent appointment of Brian Pereira, M.D. as President and Chief Executive Officer of Visterra this past summer.
Researchers at the University of Colorado School of Medicine have figured out intimate details of how the hepatitis C virus takes over an invaded cell, a breakthrough that could point to way for new treatments for the virus.
› Verified 8 days ago
Dr. Tracy Lawrence-black, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 95 Bradhurst Ave, Valhalla, NY 10595 Phone: 914-592-7555 Fax: 866-310-5326 | |
Dr. Reeja Vembenil, Pediatrics Medicare: Medicare Enrolled Practice Location: 95 Grasslands Rd, Rnicu, 2nd Floor, Mf Children's Hosp At Wmc, Valhalla, NY 10595 Phone: 914-493-8558 | |
Sahar Al Baroudi, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 100 Woods Road, Westchester Medical Center, Valhalla, NY 10595 Phone: 402-310-2631 | |
Dr. Michele Alexandra Lim Ledesma, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 503 Grasslands Rd Ste 200, Valhalla, NY 10595 Phone: 914-304-5250 Fax: 914-345-1752 | |
Dr. Rachel T Redlich, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 40 Sunshine Cottage Rd, Dept Of Pediatrics, Ny Medical College, Valhalla, NY 10595 Phone: 914-493-7235 | |
Tanvi Devi, Pediatrics Medicare: Medicare Enrolled Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 718-741-2467 | |
Dr. Jaimee Marie Bogusz Shand, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-7513 |